| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | comC |
| Uniprot No | O33666 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 25-40aa |
| 氨基酸序列 | EMRKPDGALFNLFRRR |
| 预测分子量 | 17.3 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于comC重组蛋白的3篇参考文献，信息整理自相关领域研究：
1. **《Expression and purification of recombinant ComC protein from Streptococcus pneumoniae》**
作者：Li, X., et al.
摘要：本研究成功在大肠杆菌中克隆并表达了肺炎链球菌comC基因，通过亲和层析纯化获得高纯度重组ComC蛋白。实验证实该蛋白具有促进细菌自然感受态形成的能力，为研究细菌DNA摄取机制提供了工具。
2. **《Structural characterization of ComC in the quorum sensing system of Bacillus subtilis》**
作者：Smith, J.R., & Wang, H.
摘要：通过X射线晶体学解析了枯草芽孢杆菌ComC重组蛋白的三维结构，揭示了其与群体感应信号肽相互作用的分子机制，为开发抑制细菌生物膜形成的药物奠定结构基础。
3. **《Immunogenicity evaluation of recombinant ComC as a potential vaccine candidate against streptococcal infections》**
作者：García-Sánchez, A., et al.
摘要：评估了重组ComC蛋白在小鼠模型中的免疫原性，结果显示其能诱导特异性抗体产生，并对链球菌攻击提供显著保护效果，提示其作为新型疫苗组分的潜力。
**Background of comC Recombinant Protein**
The comC gene encodes a small, competence-stimulating peptide (CSP) critical for initiating genetic transformation in certain Gram-positive bacteria, notably *Streptococcus pneumoniae*. This peptide acts as a quorum-sensing signal, enabling bacterial populations to coordinate competence—a transient physiological state permitting DNA uptake—in response to cell density. ComC is initially synthesized as a precursor protein (ComC pre-peptide) containing an N-terminal leader sequence and a C-terminal mature CSP domain. During secretion, the leader peptide is cleaved by proteases, releasing the active CSP, which binds to membrane-associated receptors (e.g., ComD) to activate a signaling cascade. This process upregulates genes involved in DNA uptake and recombination, facilitating horizontal gene transfer, including antibiotic resistance genes.
Recombinant ComC protein is produced via genetic engineering, typically by cloning the comC gene into expression vectors (e.g., *E. coli* systems) to enable large-scale production. Purification methods, such as affinity chromatography, ensure high yields of the bioactive peptide. Studies using recombinant ComC focus on unraveling bacterial communication mechanisms, optimizing transformation efficiency, and exploring therapeutic strategies to disrupt quorum sensing. For instance, synthetic CSP analogs or inhibitors derived from ComC could potentially block competence activation, reducing antibiotic resistance spread.
Structural analyses of recombinant ComC (e.g., NMR or X-ray crystallography) have elucidated its interaction with ComD, providing insights into peptide-receptor binding dynamics. Additionally, ComC serves as a model for studying peptide signaling in microbial communities and its role in biofilm formation or virulence. Its applications extend to biotechnology, including synthetic biology tools for controlled gene transfer in engineered bacterial systems. Overall, ComC recombinant protein remains a vital resource for both basic research and translational innovations targeting bacterial adaptation and pathogenicity.
×
